氨甲环酸在心脏手术中的暴露-反应关系
结果显示,低剂量方案(总剂量约20 mg/kg)即可接近80%有效浓度,而高剂量方案(总剂量80-100 mg/kg)超过90%有效浓度;两者在48小时失血量上仅相差58 ml,红细胞输血率绝对差异为2%。与未使用氨甲环酸相比,低剂量和高剂量方案分别使癫痫风险增加1.2倍和2倍,但绝对风险增加仅在长时间开腔手术中具有临床意义。结论认为低剂量氨甲环酸似乎是减少出血的合适方案。
要点
- 低剂量氨甲环酸(约20 mg/kg)即可接近80%有效浓度,减少术后失血。
- 高剂量方案(80-100 mg/kg)相比低剂量仅减少48小时失血58 ml,输血率差异2%。
- 高剂量方案使癫痫风险增加2倍,低剂量增加1.2倍,绝对风险增加仅在长时间开腔手术中有临床意义。
核心结论
- 在体外循环心脏手术中,低剂量氨甲环酸似乎是减少出血结局的合适方案。
研究设计与样本
- 使用群体药代动力学模型预测各研究组的氨甲环酸浓度,并通过非线性混合效应模型进行基于模型的荟萃分析。
主要发现
- 氨甲环酸减少术后失血的最大效应为40%(95%可信区间34至47%),EC50为5.6 mg/l(95%可信区间0.7至11 mg/l)。
- 低剂量方案的暴露值接近80%有效浓度,高剂量方案超过90%有效浓度。
- 两种方案预测的术后48小时累积失血量相差58 ml,红细胞输血率绝对差异为2%。
- 与未使用氨甲环酸相比,低剂量和高剂量方案分别使癫痫风险增加1.2倍和2倍,但绝对风险增加仅在长时间开腔手术中具有临床意义。
临床怎么用
- 在体外循环心脏手术中,可优先考虑低剂量氨甲环酸方案以减少出血,同时降低癫痫风险。
- 对于长时间开腔手术患者,需权衡高剂量氨甲环酸带来的癫痫绝对风险增加。
局限性
- 结果基于观察性数据,依赖于预测氨甲环酸暴露无偏倚及纳入研究质量,需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It is unclear whether high-dose regimens of tranexamic acid in cardiac surgery (total dose, 80 to 100 mg/kg) confer a clinical advantage over low-dose regimens (total dose, approximately 20 mg/kg), particularly as tranexamic acid-associated seizure may be dose-related. The authors' aim was to characterize the exposure-response relationship of this drug. METHODS: Databases were searched for randomized controlled trials of intravenous tranexamic acid in adult patients undergoing cardiopulmonary bypass surgery. Observational studies were added for seizure assessment. Tranexamic acid concentrations were predicted in each arm of each study using a population pharmacokinetic model. The exposure-response relationship was evaluated by performing a model-based meta-analysis using nonlinear mixed-effect models. RESULTS: Sixty-four randomized controlled trials and 18 observational studies (49,817 patients) were included. Seventy-three different regimens of tranexamic acid were identified, with the total dose administered ranging from 5.5 mg/kg to 20 g. The maximum effect of tranexamic acid for postoperative blood loss reduction was 40% (95% credible interval, 34 to 47%), and the EC50 was 5.6 mg/l (95% credible interval, 0.7 to 11 mg/l). Exposure values with low-dose regimens approached the 80% effective concentration, whereas with high-dose regimens, they exceeded the 90% effective concentration. The predicted cumulative blood loss up to 48 h postsurgery differed by 58 ml between the two regimens, and the absolute difference in erythrocyte transfusion rate was 2%. Compared to no tranexamic acid, low-dose and high-dose regimens increased the risk of seizure by 1.2-fold and 2-fold, respectively. However, the absolute risk increase was only clinically meaningful in the context of prolonged open-chamber surgery. CONCLUSIONS: In cardiopulmonary bypass surgery, low-dose tranexamic acid seems to be an appropriate regimen for reducing bleeding outcomes. This meta-analysis has to be interpreted with caution because the results are observational and dependent on the lack of bias of the predicted tranexamic acid exposures and the quality of the included studies.
引用
- Zufferey PJ, Lanoiselée J, Graouch B, et al. Exposure-Response Relationship of Tranexamic Acid in Cardiac Surgery. Anesthesiology. 2021. PMID: 33316069. doi:10.1097/ALN.0000000000003633
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。